U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07613710) titled 'A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy' on May 15.

Brief Summary: The purpose of the trial is to determine that Lu AH69593 is safe and well tolerated. The trial will also look at how the body processes Lu AH69593 with and without food.

Study Start Date: June 13, 2025

Study Type: INTERVENTIONAL

Condition: Narcolepsy

Intervention: DRUG: Lu AH69593

Lu AH69593 will be administered per schedule specified in the arm description.

DRUG: Placebo

Placebo will be administered per schedule specified in the arm description.

Recruitment Status: RECRUITING

Sponsor: H. Lundb...